There is laboratory evidence that cholesterol lowering medications (statins) inhibit the
growth of breast cancer cells. Clinical studies are controversial but some show that women
taking statins are less likely to get breast cancer. This ongoing randomized trial compares
one-year of atorvastatin (Lipitor™) or placebo for lowering mammography-defined breast
density and other surrogate markers associated with breast cancer risk.
Phase:
Phase 2
Details
Lead Sponsor:
University of Vermont
Collaborators:
Breast Cancer Research Foundation Cancer and Leukemia Group B